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INTRODUCTION
Gastric cancer is the most common cancer in Korea. It is
an unfortunate reality for many Koreans. It has been a very
serious disease and is naturally resistant to many anticancer
drugs, so the results after surgery and chemotherapy have been
disappointing. To reduce the mortality and improve the effec-
tiveness of therapy, many studies have tried to find key bio-
markers. Biomarkers are important molecular signposts of
the biologic state of a cell at a specific condition. Active genes,
their respective protein products, and other organic chemicals
made by the cell create these signposts. Proteomic technolo-
gies are providing the tools needed to discover and identify
disease associated-biomarkers.
After the completion of human genome project, the prac-
tice of medicine will be altered fundamentally, which includes
the identification of genes (genomics) that are involved in the
appearance, progression, and treatment of cancer, the answers
to what those specific genes do and how they interact in com-
munication networks (functional genomics), and the roles
played by their protein products (proteomics) in molecular
pathways.
There have been many studies including analysis of prog-
nostic factors, development of chemotherapeutic agents, and
the search for the early detecting molecules, but there are cur-
rently very few molecular markers that are clinically in use.
Proteomics is one of the technologies that rapidly change our
approach to cancer research. The conventional proteomics has
been the high resolution 2-D gel electrophoresis (1) followed
by computational image analysis and protein identification
using mass spectrometry. The proteomic studies could lead
to the molecular characterization of cellular events associated
with cancer progression, signaling, and developmental stages
(2, 3), and these studies with clinical tumor samples have led
to the defining of cancer-specific protein markers which will
be the basis for developing new methods for early diagnosis
and detection and clues to understand the molecular charac-
terization of cancer progression (3-6).
In this study, we tried to find biomarkers in human gastric
cancer tissue via proteomics as high throughput method.
MATERIALS AND METHODS
Materials
Eleven human stomach tissue samples were prepared from
resection materials of cancer patients in Dankook University
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The Proteomics Approach to Find Biomarkers in Gastric Cancer
Gastric cancer is a very serious disease and is naturally resistant to many anticancer
drugs. To reduce the mortality and improve the effectiveness of therapy, many stud-
ies have tried to find key biomarkers. Proteomic technologies are providing the tools
needed to discover and identify disease-associating biomarkers. The proteomic study
of gastric cancer establishes any specific events that lead to cancer, and it provides
a direct way to define the true function of genes. Using two dimensional (2-D) elec-
trophoresis of the stomach cancer tissue, we have gained about 1,500 spots in each
gel, and 140 protein spots also were identified. Among the identified proteins, there
were seven over-expressed proteins in stomach cancer tissue: NSP3, transgelin,
prohibitin, heat shock protein (hsp) 27 and variant, protein disulfide isomerase A3,
unnamed protein product and glucose regulated protein. There were also seven
under-expressed proteins in stomach cancer: Apolipoprotein A-1, p20, nucleoside
diphosphate isomerase A, alpha 1 antitrypsin, desmin, serum albumin and sero-
transferrin.
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Hospital. Resections were examined by a pathologist and nor-
mal tissue samples were prepared from noncancerous regions.
The margin tissue samples were prepared from noncancerous
regions 5 cm apart from primary tumor. Their clinicopatho-
logic characters were described in Table 1.
The power supply, the 2D electrophoresis system (PRO-
TEAN IEF cell, PROTEAN II Xi cell), the Trans-Blot Cell,
CHAPS, DTT, SDS, iodoacetamide, ampholyte, and IPG
(Immobilized pH gradient) and strip were purchased from
Bio-Rad (Richmond, CA, U.S.A.). DNase and the protein pI
marker were from Amersham-Pharmacia (Bucks, U.K.). Acry-
lamide, N,N′ -methylene-bis-acrylamide, TEMED, ammo-
nium persulfate, Trisma base, glycine, methanol, glacial ac-
etic acid, glycerol, potassium chloride, urea, thiourea, ph-
enylmethyl-sulfonylfluoride (PMSF), ethylenedinitrilotetra
acetic acid disodium salt (EDTA), benzamidine, and brilliant
blue R-250 were from Sigma-Aldrich (Missouri, U.S.A.).
Sample Preparation
Proteins were extracted from human stomach tissue as in-
structed by German Heart Center method (http://userpage.
chemie.fu-berlin.de/~pleiss/tissue.html). Stomach tissue was
washed in 50 mM Tris-HCl pH 7.1, 100 mM KCl, 60 mM
EDTA, 5.8 mM benzamidine and 0.2 mM PMSF, and was
lyophilized for 1hr. Samples of 30 mg were crushed by liquid
nitrogen and were solubilized in 100  L buffer containing 7
M urea, 2 M thiourea, 4% CHAPS, 100 mM DTT, 25 mM
tris-HCl pH 7.1, 50 mM KCl, and 0.2% Bio-Lyte 3/10 am-
pholyte. DNase was added to 210 U and was incubated at room
temperature for 30 min. Insoluble materials were removed by
centrifugation at 13,000 rpm for 20 min at 10℃. Protein con-
centration was determined using a commercial Bradford reagent
(Bio-Rad) and the samples were stored at -70℃until use.
Two-dimensional Electrophoresis
The first-dimensional gel separation was carried out with
17 cm pH 4-7 IPG strips following the manufacturer’ s pro-
tocol (Bio-Rad) with minor modifications. 1mg of the protein
was loaded and Iso-electric focusing (IEF) was performed using
PROTEAN IEF Cell for a total of 145 kVh at 20℃. After
IEF, strips were equilibrated for 15 min in 6 M urea, 2% SDS,
0.05 M Tris-HCl pH 8.8, and 20% glycerol containing 2%
DTT, and then equilibrated again for 15 min in the same buffer
containing 2.5% iodoacetamide. Equilibrated IPG strips were
transferred onto 13% uniform polyacrylamide gels and then
were run in PROTEAN II xi cell tank at 30 mA per gel. The
gels were visualized using the Coomassie brilliant blue R250
staining method.
After the staining, 2D gels were imaged using Powerlook
1,100 (UMAX, Fremont, CA, U.S.A.) and the images were
analyzed using Melanie III (Genebio, Geneva, Switzerland).
Protein Identification
Proteins that were differentially pressed in the tumor tis-
sue were identified by using the database from Gyeongsang
National University (http://proteome.gsnu.ac.kr/index1.html)
and by matrix-assisted laser desorption/ionization-time of
flight (MALDI-TOF) analysis (Yonsei Proteome Research
Center, Seoul, Korea) with the search programs called Pro-
Found (http://129.85.19.192/profound_bin/WebProFound.
exe), Mascot (http://www.matrixscience.com/cgi/index.
pl?page=../home.html), and MS-FIT (http:// prospector.ucsf.
edu/ucsfhtml4.0/msfit.htm).
Age (yr) Sex Cell type Stage Borrmann type
79 M Signet ring IIIb III
58 F Poor IIIb II
61 M Poor IV IV
51 F Moderate IIIa I
41 F Scirrhous IIIb IV
67 M Poor Ib II
47 M Signet ring IIIa II
67 M Moderate IIIa II
44 M Moderate IIIa II
68 M Poor IV II
52 M Poor IIIb III
Table 1. Clinico-pathological characters of 11 stomach cancer
patients
Fig. 1. Two-dimension electrophoresis pattern of stomach tissue.
Proteins were identified using MALDI-TOF mass spectrometry
(Yonsei Proteome Research Center) and database comparisons
(Gyeongsang National Univ).
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RESULTS
Two-dimensional electrophoresis of the stomach cancer
tissue produced about 1,500 spots each. A electrophoresis
feature is shown in Fig. 1. In this figure, all proteins that have
been identified to date have been marked with arrows and
accession number. Spots marked with circles and arrows are
differentially expressed proteins in normal, margin, and can-
cer tissues (Fig. 2). In this study, we compared cancer tissue
with normal tissue to obtain definite differential expressions
of protein between them. A comparison of stomach cancer
tissue with normal tissue in same patients showed the seven
proteins, namely: NSP3, transgelin, prohibitin, heat shock
protein (hsp) 27 and variant, protein disulfide isomerase A3,
unnamed protein product, and glucose-regulated protein were
over-expressed (Table 2). The seven proteins, namely: apo-
lipoprotein A-1, p20, nucleoside diphosphate isomerase A,
alpha 1 antitrypsin, desmin, serum albumin, and serotrans-
Fig. 2. 2DE patterns showing the under-expression of desmoplakin I (indicated by arrows) and up-regulation of prohibitin (indicated by
circles) in stomach cancer tissue samples (G-I) as compared to normal (A-C) and margin stomach tissue samples (D-F).
A B C
D E F
G H I
Acc. #
Apparent
pI/Mw (kDa)
Protrin identified
Abun-
dance
Level
Calculat-
ed
pI/Mw
(kDa)
BAA84968 5.22/35.74 NSP3 2.7 4.66/34
Q01995 8.90/22.60 Transgelin (SM22-alpha) 2.2 4.79/36
P35232 5.57/29.89 Prohibitin 2.0 5.67/31
P04792 7.83/22.33 Heat-shock 27kDa protein 5.3 6.19/30
P30101 6.00/56.78 Protein disulfide isomerase A3 3.2 6.07/29
BAB70985 7.23/42.45 Unnamed protrin product 2.5 5.47/66
NP_053955 6.87/28.44 Glucose regulated protein, 2.5 6.05/64
58 kDa
Acc.#: accession numbers from SWISS-PROT database.
Table 2. Over-expressed Proteins in Human Stomach Cancer
Tissue
Acc. #
Apparent
pI/Mw (kDa)
Protrin identified
Abundance
Level
Calculat-
ed
pI/Mw
(kDa)
P02647 5.56/30.78 Apolipoprotein A-1 2.4 5.43/28
B53814 6.00/17.17 P20 1.4 6.43/22
P15531 6.00/22.00 Nucleoside diphosphate  3.3 5.38/17
isomerase A
P01009 5.37/46.74 Alpha-1-antitrypsin 1.7 5.10/62
P17661 5.21/53.39 Desmin 3.2 5.52/59
P02768 6.18/80.00 Serum albumin 6.4 5.92/69
P02787 6.81/77.05 Serotransfemin 4.2 6.59/91
Acc.#: accession numbers from SWISS-PROT database.
Table 3. Under-expressed Proteins in Human Stomach Cancer
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ferrin were under-expressed (Table 3).
DISCUSSION
Recent advances in genomics and proteomics hold great
potential for diagnostic, prognostic, and therapeutic applica-
tions (7). Genes work at the protein level, and comparisons of
transcripts and corresponding protein expressions have shown
that mRNA and protein levels are not necessarily highly cor-
relative. The proteomic study includes post-translational mod-
ifications such as acetylation, ubiquitination, phosphorylation,
or glycosylation (8, 9). Proteomic methods detect the func-
tioning units of expressed genes (10) using protein fingerprint
(11). The proteomic results express both the intrinsic genet-
ic effect on cell and the impact of its environment, so it is very
valuable to determine biomarkers.
Today, it has become common to read that proteins are the
main functional outputs of genes, and the proteomics will lead
biology and medicine beyond genomics. The molecular events
into neoplaplastic progression are complex and diverse, and
they remain incompletely characterized. The identification,
quantification, classification, and functional assignment of
proteins will be essential to the full understanding of these
molecular events. Such information will likely prove to be
crucial in cancer prognosis, diagnosis, prevention and therapy
with the ultimate goods being therapeutic target discovery,
rational drug design and the identification of early detection
surrogate biomarkers (12, 13).
In this study, we have evaluated our 2-D data from refer-
ence 2-D map (from Gyeongsang National University, Jinju,
Korea). The over- and under-expressed proteins were confirmed
by MALDI-TOF mass spectrometry (Yonsei Proteome Re-
search Center, Seoul, Korea). There are useful URLS for other
cancer, bladder, colorectal, breast, liver, and leukemia, but
there is little data for stomach cancer (14). We obtained seven
over-expressed proteins (NSP3, transgelin, prohibitin, HSP27,
protein disulfide isomerase A3, unnamed protein product and
glucose regulated protein) in cancer. In thermoresistant human
gastric cancer cell line study, stratifin, cytokeratin 7-9, cal-
reticulin, glucose regulated protein 78, and heat shock pro-
teins (hsp27, hsx70 variant, hsp 27 variant) were reported as
over-expressed protein (15). They declared that the develop-
ment of thermoresistance in stomach cancer cell and their
chemoresistance variants is a complex phenomenon that is not
only associated with the expression of HSPs but of molecular
chaperones at every subcellular level. In our study, the cyto-
plasmic proteins (transgelin, prohibitin, and HSP 27) were
identified as over-expressed proteins which are molecular chap-
erones. Also, we obtained seven under-expressed proteins (apo-
lipoprotein A-1, p20, nucleoside diphosphate isomerase A,
alpha-1-antitrypsin, desmin, serum albumin, and serotrans-
ferrin) in human gastric cancer tissue. The extracellular pro-
teins (serum albumin, serotransferrin, and alpha-1-antitrypsin)
were identified as under-expressed proteins in cancer tissue.
In thermoresistant cancer cell line study, eight proteins (14-
3-3, aldehyde dehydrogenase 1, annexin 1, lipocortin 1 vari-
ant, initiation factor-5A, initiation factor-5A variant, reticu-
localbin, and vimentin) were reported as under- expressed pro-
teins (15).
We analyzed primary tumor biopsies and normal tissues in
same patients. The primary tumor biopsies may contain sev-
eral different cell types other than carcinoma cells, so the exact
defining for major cellular changes during the conversion of
normal to malignant stomach is limited. It is related to defects
in a multiplicity of 2-D features. On the contrary cell line in
culture, being free of any tissue components may have mul-
tiplicity, but may not represent their exact feature in vivo co-
unter part. Clearly, more work and data are required to under-
stand and clarify the exact role of proteins for progression of
carcinoma.
In this study, we observed the over- and under-expressed
proteins in human gastric cancer tissue. We hope that these
results shall be correlated with clinical data in recent forthcom-
ing day to define clinically useful biomarkers. The identifi-
cation of functioning protein is essentially needed to provide
more effective therapy for patients suffering from gastric car-
cinoma.
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